The need to improve current psychopharmacotherapy before
developing new drugs

J 2014

The need to improve current psychopharmacotherapy before developing new drugs

ČEŠKOVÁ, Eva

Základní údaje

Originální název

The need to improve current psychopharmacotherapy before developing new drugs

Autoři

ČEŠKOVÁ, Eva (203 Česká republika, garant, domácí)

Vydání

EXPERT OPINION ON PHARMACOTHERAPY, LONDON, INFORMA HEALTHCARE, 2014, 1465-6566

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 3.534

Kód RIV

RIV/00216224:14740/14:00082092

Organizační jednotka

Středoevropský technologický institut

DOI

http://dx.doi.org/10.1517/14656566.2014.941806

UT WoS

000341993800001

Klíčová slova anglicky

genotyping; non- adherence; phenotyping; psychopharmacotherapy; therapeutic drug monitoring; treatment optimization

Štítky

poznámka, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 29. 4. 2016 12:33, Mgr. Eva Špillingová

Anotace

V originále

CNS research has become unprofitable, and several pharmaceutical companies have reduced financial support for developing new CNS drugs. Until the situation can be changed, it is our duty to optimize the usage of the currently available psychoactive drugs. Several tools for optimizing pharmacotherapy are available, such as therapeutic drug monitoring and genotyping and phenotyping CYP enzymes. Further medical treatment and healthcare provision for patients with severe mental disorders should be improved. Knowledge of psychopharmacotherapy influences the choices of medication and outcomes; therefore, future psychiatrists should have a greater knowledge of pharmacodynamics, pharmacokinetics and pharmacogenetics.

Návaznosti

ED1.1.00/02.0068, projekt VaV

Název: CEITEC - central european institute of technology

Citovat

ČEŠKOVÁ, Eva. The need to improve current psychopharmacotherapy before developing new drugs. EXPERT OPINION ON PHARMACOTHERAPY. LONDON: INFORMA HEALTHCARE, 2014, roč. 15, č. 14, s. 1969-1973. ISSN 1465-6566. Dostupné z: https://dx.doi.org/10.1517/14656566.2014.941806.

@article{1196541,
   author = {Češková, Eva},
   article_location = {LONDON},
   article_number = {14},
   doi = {http://dx.doi.org/10.1517/14656566.2014.941806},
   keywords = {genotyping; non- adherence; phenotyping; psychopharmacotherapy; therapeutic drug monitoring; treatment optimization},
   language = {eng},
   issn = {1465-6566},
   journal = {EXPERT OPINION ON PHARMACOTHERAPY},
   note = {Scopus - Review; WOS - Editorial},
   title = {The need to improve current psychopharmacotherapy before developing new drugs},
   url = {http://informahealthcare.com/doi/abs/10.1517/14656566.2014.941806},
   volume = {15},
   year = {2014}
}

TY  - JOUR
ID  - 1196541
AU  - Češková, Eva
PY  - 2014
TI  - The need to improve current psychopharmacotherapy before developing new drugs
JF  - EXPERT OPINION ON PHARMACOTHERAPY
VL  - 15
IS  - 14
SP  - 1969-1973
EP  - 1969-1973
PB  - INFORMA HEALTHCARE
SN  - 14656566
N1  - Scopus - Review; WOS - Editorial
KW  - genotyping
KW  - non- adherence
KW  - phenotyping
KW  - psychopharmacotherapy
KW  - therapeutic drug monitoring
KW  - treatment optimization
UR  - http://informahealthcare.com/doi/abs/10.1517/14656566.2014.941806
L2  - http://informahealthcare.com/doi/abs/10.1517/14656566.2014.941806
N2  - CNS research has become unprofitable, and several pharmaceutical companies have reduced financial support for developing new CNS drugs. Until the situation can be changed, it is our duty to optimize the usage of the currently available psychoactive drugs. Several tools for optimizing pharmacotherapy are available, such as therapeutic drug monitoring and genotyping and phenotyping CYP enzymes. Further medical treatment and healthcare provision for patients with severe mental disorders should be improved. Knowledge of psychopharmacotherapy influences the choices of medication and outcomes; therefore, future psychiatrists should have a greater knowledge of pharmacodynamics, pharmacokinetics and pharmacogenetics.
ER  -

ČEŠKOVÁ, Eva. The need to improve current psychopharmacotherapy before developing new drugs. \textit{EXPERT OPINION ON PHARMACOTHERAPY}. LONDON: INFORMA HEALTHCARE, 2014, roč.~15, č.~14, s.~1969-1973. ISSN~1465-6566. Dostupné z: https://dx.doi.org/10.1517/14656566.2014.941806.

Podrobný výpis o publikaci